West Pharmaceutical Services (WST) Exchange Rate Effect (2009 - 2026)

West Pharmaceutical Services (WST) has reported Exchange Rate Effect for 18 consecutive years, with -$1.6 million the latest figure, recorded in Q2 2026.

• Quarterly Exchange Rate Effect fell 108.65% year-over-year to -$1.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$14.1 million (down 191.56% YoY) and the FY2025 annual result came in at $22.9 million, up 207.01% from the prior year.
• Exchange Rate Effect climbed to -$1.6 million in Q2 2026 per WST's latest filing, from -$8.4 million in the prior quarter.
• Over the last five years, Exchange Rate Effect for WST reached as high as $38.8 million in Q4 2022 and fell as low as -$24.1 million in Q3 2022.
• A 5-year average of -$422222.2 and a median of -$1.3 million in 2024 frame the typical range for Exchange Rate Effect.
• Annual changes were most pronounced in 2022 — Exchange Rate Effect plunged 643.24% — and 2025, when it soared 1781.82%.
• Year by year, Exchange Rate Effect stood at $38.8 million in 2022, then slumped by 62.63% to $14.5 million in 2023, then plunged by 256.55% to -$22.7 million in 2024, then jumped by 97.8% to -$500000.0 in 2025, then tumbled by 220.0% to -$1.6 million in 2026.
• According to Business Quant data, Exchange Rate Effect over the past three periods registered -$1.6 million, -$8.4 million, and -$500000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.